9-109379617-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_002829.4(PTPN3):āc.2681T>Cā(p.Val894Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000524 in 1,613,980 control chromosomes in the GnomAD database, including 3 homozygotes. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00030 ( 1 hom., cov: 32)
Exomes š: 0.00055 ( 2 hom. )
Consequence
PTPN3
NM_002829.4 missense
NM_002829.4 missense
Scores
6
7
6
Clinical Significance
Conservation
PhyloP100: 9.32
Genes affected
PTPN3 (HGNC:9655): (protein tyrosine phosphatase non-receptor type 3) The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This protein contains a C-terminal PTP domain and an N-terminal domain homologous to the band 4.1 superfamily of cytoskeletal-associated proteins. P97, a cell cycle regulator involved in a variety of membrane related functions, has been shown to be a substrate of this PTP. This PTP was also found to interact with, and be regulated by adaptor protein 14-3-3 beta. Several alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PTPN3 | ENST00000374541.4 | c.2681T>C | p.Val894Ala | missense_variant | 26/26 | 5 | NM_002829.4 | ENSP00000363667.1 | ||
PTPN3 | ENST00000412145.5 | c.2288T>C | p.Val763Ala | missense_variant | 21/21 | 1 | ENSP00000416654.1 | |||
PTPN3 | ENST00000446349.5 | c.2153T>C | p.Val718Ala | missense_variant | 20/20 | 1 | ENSP00000395384.1 | |||
PTPN3 | ENST00000262539 | c.*277T>C | 3_prime_UTR_variant | 26/26 | 5 | ENSP00000262539.4 |
Frequencies
GnomAD3 genomes AF: 0.000296 AC: 45AN: 152220Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
45
AN:
152220
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000247 AC: 62AN: 251424Hom.: 0 AF XY: 0.000228 AC XY: 31AN XY: 135888
GnomAD3 exomes
AF:
AC:
62
AN:
251424
Hom.:
AF XY:
AC XY:
31
AN XY:
135888
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000547 AC: 800AN: 1461760Hom.: 2 Cov.: 30 AF XY: 0.000521 AC XY: 379AN XY: 727200
GnomAD4 exome
AF:
AC:
800
AN:
1461760
Hom.:
Cov.:
30
AF XY:
AC XY:
379
AN XY:
727200
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000296 AC: 45AN: 152220Hom.: 1 Cov.: 32 AF XY: 0.000269 AC XY: 20AN XY: 74366
GnomAD4 genome
AF:
AC:
45
AN:
152220
Hom.:
Cov.:
32
AF XY:
AC XY:
20
AN XY:
74366
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
3
ALSPAC
AF:
AC:
3
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
5
ExAC
AF:
AC:
32
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 23, 2023 | The c.2681T>C (p.V894A) alteration is located in exon 26 (coding exon 25) of the PTPN3 gene. This alteration results from a T to C substitution at nucleotide position 2681, causing the valine (V) at amino acid position 894 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
.;.;D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D
M_CAP
Benign
D
MetaRNN
Uncertain
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;.;L
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;D;D
REVEL
Uncertain
Sift
Uncertain
D;D;D
Sift4G
Pathogenic
D;D;D
Polyphen
0.89
.;.;P
Vest4
MVP
MPC
0.94
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at